FDA seeks comments on new medical-imaging guidance

10/13/2008 | HealthImaging.com

The FDA is accepting public comments on a draft guidance for makers of medical-imaging drugs and devices that provide contrast enhancement. The guidance focuses on developing new contrast indications for imaging devices that use approved drugs or biological products. It also contains recommendations to promote the timely and effective evaluation and regulation of imaging drugs and devices.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC